Assessment of the REPLACE study composite endpoint in the PATENT study and association with long-term outcomes in riociguat-treated patients.
Assessment of the REPLACE study composite endpoint in the PATENT study and association with long-term outcomes in riociguat-treated patients.
Contenido principal del artículo
Resumen
Assessment of the REPLACE study composite endpoint in the PATENT
Detalles del artículo
Referencias (VER)
Hoeper MH, et al. Eur Respir J 2017;50:PA2417.
Ghofrani HA, et al. N Engl J Med 2013;25:369:330–40.
Ghofrani HA, et al. Lancet Respir Med 2016;4:361–71.
Li F, et al. J Am Stat Assoc 2018;113:390–400.